Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea

Patients in the coronary intensive care unit receiving ticagrelor and meeting the inclusion criteria will be included. The study includes two groups: a control group receiving standard care and an experimental group receiving standard care plus hand fan therapy. A total of 110 participants (55 per group) will be recruited. Randomization will be performed using a computer-based randomization program. Due to the nature of the intervention and sample characteristics, participants and the researcher will not be blinded. Data will be analyzed by a statistician not involved in the study, and the findings will be reported.

Inclusion criteria

• Between the ages of 18 and 65,
• No severe hearing and vision problems,
• Can speak and understand Turkish,
• Easy to communicate with,
• First-time sufferer of acute coronary syndrome (ACS) for the first time,
• Decided to start ticagrelor therapy,
• Able to adapt to treatment,
• Individuals who volunteered to participate in the research.

Exclusion criteria

• Having any problem that prevents you from communicating cognitively, emotionally and verbally,
• Obstructive sleep abnormalities,
• Have a disease that affects respiratory function (stage IV cancer, bronchial asthma, COVID-19, lung cancer, pulmonary edema, chronic obstructive pulmonary disease, pulmonary hypertension, pulmonary embolism, pneumonia or bronchitis, etc.),
• With metabolic abnormalities,
• Intubated after the procedure,
• Previously treated with ticagrelor,
• Individuals who did not volunteer to participate in the study. Losses to follow up
• Individuals who wish to leave the study voluntarily.
• Saturation value below 95%,
• The one with the arrest,
• Who will not be able to fulfill the requirements of the work,
• Individuals with life-threatening conditions